NCT00899379View on ClinicalTrials.gov

Treatment of Multiple Attacks of Acute Migraine (0462-025)

PHASE3CompletedINTERVENTIONAL
Enrollment

473

Participants

Timeline

Start Date

April 30, 1995

Primary Completion Date

January 31, 1996

Study Completion Date

April 30, 1996

Conditions
Migraine Headache
Interventions
DRUG

rizatriptan benzoate

Rizatriptan 10 mg p.o. at onset of moderate to severe migraine headache

DRUG

Comparator: Placebo

Placebo to Rizatriptan, Oral Tablet

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00899379 - Treatment of Multiple Attacks of Acute Migraine (0462-025) | Biotech Hunter | Biotech Hunter